IRADIMED CORP

IRADIMED CORPORATION announced that its President and CEO, Roger Susi, and CFO, Jack Glenn, will attend the Goldman Sachs 47th Annual Global Healthcare Conference. The conference is scheduled for June 8 10, 2026, in Miami Beach, Florida. Investors have the opportunity to schedule one-on-one meetings with Iradimed management through their Goldman Sachs representatives.

IRADIMED reported strong financial results for the first quarter of 2026, with revenue increasing 13% to $22.0 million and net income rising 24.1% to $5.8 million. Diluted earnings per share reached $0.45, up from $0.37 in the prior year. The company also saw a significant increase in cash and cash equivalents, reaching $56.374 million, and its Board declared a quarterly cash dividend of $0.20 per share.

IRADIMED CORPORATION reported strong first-quarter 2026 financial results, with revenue increasing 13% to $22.0 million and GAAP diluted EPS rising 22% to $0.45. The company also announced a regular quarterly cash dividend of $0.20 per share and reaffirmed its full-year 2026 revenue and earnings guidance. Additionally, Iradimed commercially launched its next-generation 3870 MRI-compatible IV infusion pump system, with strong early order activity.

IRADIMED CORP announced its 2026 Annual Meeting of Stockholders will be held on Tuesday, June 23, 2026, at 10:00 a.m. Eastern Time. Stockholders as of the April 24, 2026 record date will vote on the election of five directors, the ratification of RSM US LLP as the independent auditor for fiscal year 2026, and a non-binding advisory resolution on fiscal 2025 executive compensation. The Board of Directors unanimously recommends a vote "FOR" all proposals.

IRADIMED CORPORATION announced it will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Following the release, Iradimed management will host a conference call on the same day at 11:00 a.m. Eastern Time to discuss the results and answer questions. Interested parties can register online to participate or listen to the call live via the company's investor relations website, where a recording will also be available.

IRADIMED CORP (NASDAQ: IRMD) announced its participation in the 25th Annual Needham Virtual Healthcare Conference, scheduled from April 13-16, 2026. The company's CFO, Jack Glenn, will host one-on-one meetings with institutional investors during the event. This engagement provides a platform for IRADIMED to communicate its strategic vision and highlight its innovative MRI-compatible medical devices, including the MRidium® IV infusion pump system and the 3880 patient vital signs monitoring system, to a targeted investor audience.